In contrast, TRIM21/Ro52 promotes cancer cell proliferation and migration in glioma and thyroid cancer, and it increases drug resistance in colorectal and pancreatic cancers [15–17]. This evidence concerns the gene TRIM21 and central nervous system cancer.